P3 Health Partners Inc. (PIII)

NASDAQ: PIII · IEX Real-Time Price · USD

0.552

-0.004 (-0.65%)

At close: Jul 19, 2024, 4:00 PM

0.490

-0.062 (-11.30%)

Pre-market: Jul 20, 2024, 9:28 AM EDT

P3 Health Partners Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	1,353	1,266	1,049	485.54	145.89	87.7
Revenue Growth (YoY)	25.49%	20.67%	116.14%	232.80%	66.36%	-
Cost of Revenue	1,314	1,222	1,046	464.97	147.81	106.66
Gross Profit	38.4	44.34	3.71	20.57	-1.91	-18.96
Selling, General & Admin	114.67	125.6	162.38	54.89	37.23	30.41
Other Operating Expenses	86.67	86.68	1,402	0.8	0.4	0.34
Operating Expenses	201.35	212.27	1,565	55.69	37.62	30.75
Operating Income	-162.94	-167.93	-1,560.91	-35.12	-39.54	-49.71
Interest Expense / Income	16.16	15.99	11.4	9.97	3.48	-0.04
Other Expense / Income	-116.3	-128.84	-1,304.05	-4.02	-8.01	-5.87
Pretax Income	-62.8	-55.08	-268.27	-41.07	-35.01	-43.8
Income Tax	4.48	2.7	1.86	0	0	0
Net Income	-67.27	-57.77	-270.13	-41.07	-35.01	-43.8
Shares Outstanding (Basic)	119	95	42	7	-	-
Shares Outstanding (Diluted)	119	295	42	7	-	-
Shares Change	185.93%	608.51%	504.79%	-	-	-
EPS (Basic)	-0.61	-0.61	-6.50	-0.62	-0.74	-1.78
EPS (Diluted)	-0.59	-0.63	-6.50	-0.62	-0.74	-1.78
Free Cash Flow	-73.7	-77.86	-128.25	-27.52	-29.74	-32.54
Free Cash Flow Per Share	-0.62	-0.82	-3.08	-4.00	-	-
Gross Margin	2.84%	3.50%	0.35%	4.24%	-1.31%	-21.62%
Operating Margin	-12.05%	-13.26%	-148.73%	-7.23%	-27.10%	-56.69%
Profit Margin	-4.97%	-4.56%	-25.74%	-8.46%	-24.00%	-49.95%
Free Cash Flow Margin	-5.45%	-6.15%	-12.22%	-5.67%	-20.38%	-37.11%
EBITDA	40.03	47.58	-169.57	-30.31	-31.13	-43.5
EBITDA Margin	2.96%	3.76%	-16.16%	-6.24%	-21.34%	-49.61%
Depreciation & Amortization	86.67	86.68	87.29	0.8	0.4	0.34
EBIT	-46.64	-39.09	-256.86	-31.1	-31.53	-43.85
EBIT Margin	-3.45%	-3.09%	-24.48%	-6.41%	-21.61%	-50.00%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).